Kintor Pharmaceutical, a clinical-stage biotechnology company developing innovative small molecule and biological therapeutics, has entered a partnership with Hainan Visum Pharmaceutical to expand proxalutamide manufacturing.
Kintor Pharmaceutical Limited recently announced a strategic partnership with Hainan Visum Pharmaceutical Limited to expand proxalutamide manufacturing.